RMTI

Rockwell Medical, Inc. NASDAQ Listed Jan 27, 1998

Healthcare ·Drug Manufacturers - Specialty & Generic ·US · rockwellmed.com

$0.81

After hrs $0.82 +1.44%

Mkt Cap $31.9M

52w Low $0.78 2.3% of range 52w High $2.10

50d MA $0.92 200d MA $1.06

P/E (TTM) -5.9x

EV/EBITDA 9985.8x

P/B 0.9x

Debt/Equity 0.3x

ROE -14.4%

P/FCF -25.0x

RSI (14) —

ATR (14) —

Beta 1.71

50d MA $0.92

200d MA $1.06

Avg Volume 260.6K

About

Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Mar 26, 2026	AMC	0.04	-0.01	-125.0%	0.94	-1.3%	-7.6%	-9.8%	-5.2%	-0.9%	+1.6%	—
Nov 12, 2025	AMC	-0.04	-0.05	-25.0%	0.96	+2.6%	-4.5%	-3.8%	-9.4%	-8.4%	-10.0%	—
Aug 14, 2025	AMC	-0.05	-0.05	+0.0%	1.05	+1.0%	-2.9%	+0.0%	+0.0%	+0.0%	+10.5%	—
May 12, 2025	AMC	-0.03	-0.04	-33.3%	1.04	+1.9%	+2.9%	-2.9%	-5.8%	-2.9%	+0.0%	—
Mar 20, 2025	AMC	0.02	-0.02	-200.0%	1.40	-0.7%	-3.6%	-10.0%	-14.3%	-11.4%	-14.3%	—
Nov 12, 2024	AMC	0.01	0.05	+400.0%	2.83	+6.0%	-7.1%	-12.0%	-16.6%	-17.0%	-12.0%	—
Aug 8, 2024	AMC	0.00	0.01	+126.4%	2.14	+2.8%	+1.4%	+11.2%	+12.1%	+10.3%	+19.6%	—
May 14, 2024	AMC	-0.05	-0.02	+60.0%	1.70	-1.8%	+0.6%	+2.4%	+4.1%	+5.9%	+5.9%	—
Mar 21, 2024	AMC	-0.08	0.02	+125.0%	1.52	-4.6%	+12.5%	+6.6%	+8.6%	+7.9%	+9.2%	—
Nov 14, 2023	AMC	-0.12	-0.07	+41.7%	1.96	+3.1%	+12.8%	+5.1%	+5.6%	-0.5%	-3.1%	—
Aug 14, 2023	AMC	-0.12	-0.18	-50.0%	2.85	-1.1%	-3.2%	-20.7%	-22.5%	-22.5%	-17.9%	—
May 15, 2023	AMC	-0.18	-0.10	+44.4%	2.41	+2.9%	-2.9%	-3.7%	-2.1%	-2.1%	+6.6%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Mar 30	HC Wainwright & Co.	Maintains	Buy → Buy	—	$0.87	$0.86	-0.9%	-2.3%	+2.6%	+7.2%	+10.0%	+10.9%
Jan 26	HC Wainwright & Co.	Maintains	Buy → Buy	—	$1.15	$1.15	+0.0%	-5.2%	+0.0%	-1.7%	-5.2%	-7.0%
Nov 13	HC Wainwright & Co.	Maintains	Buy → Buy	—	$0.96	$0.98	+2.6%	-4.5%	-3.8%	-9.4%	-8.4%	-10.0%
Mar 24	HC Wainwright & Co.	Maintains	Buy → Buy	—	$1.35	$1.35	+0.0%	-6.7%	-11.1%	-8.1%	-11.1%	-15.6%
Dec 23	HC Wainwright & Co.	Maintains	Buy → Buy	—	$2.08	$2.08	+0.0%	+1.4%	+3.4%	+3.8%	+2.9%	-1.4%
Nov 25	HC Wainwright & Co.	Maintains	Buy → Buy	—	$2.25	$2.30	+2.2%	+2.7%	+0.0%	-1.3%	+1.8%	-0.4%
Aug 12	HC Wainwright & Co.	Maintains	Buy → Buy	—	$2.17	$2.23	+2.8%	+9.7%	+10.6%	+8.8%	+18.0%	+18.9%
May 16	HC Wainwright & Co.	Maintains	Buy → Buy	—	$1.71	$1.73	+1.2%	+1.8%	+3.5%	+5.3%	+5.3%	+5.8%
Mar 25	HC Wainwright & Co.	Maintains	Buy → Buy	—	$1.71	$1.68	-1.8%	-5.3%	-3.5%	-4.1%	-2.9%	-0.6%
Nov 15	HC Wainwright & Co.	Maintains	Buy → Buy	—	$1.96	$2.02	+3.1%	+12.8%	+5.1%	+5.6%	-0.5%	-3.1%
Oct 4	HC Wainwright & Co.	Maintains	Buy → Buy	—	$2.06	$2.05	-0.5%	+0.5%	+3.9%	+11.2%	+4.9%	+18.4%
Sep 28	HC Wainwright& Co.	Maintains	Buy → Buy	—	$1.85	$1.85	+0.0%	+8.1%	+12.4%	+9.7%	+11.4%	+11.9%
Sep 28	HC Wainwright & Co.	Maintains	Buy → Buy	—	$1.85	$1.85	+0.0%	+8.1%	+12.4%	+9.7%	+11.4%	+11.9%
Aug 15	HC Wainwright & Co.	Maintains	Buy → Buy	—	$2.85	$2.82	-1.1%	-3.2%	-20.7%	-22.5%	-22.5%	-17.9%
Jul 17	HC Wainwright & Co.	Maintains	Buy → Buy	—	$3.19	$3.49	+9.4%	+31.3%	+26.0%	+37.3%	+27.3%	+26.3%
May 30	HC Wainwright & Co.	Maintains	Buy → Buy	—	$2.39	$2.47	+3.3%	+13.0%	+38.9%	+55.2%	+76.6%	+90.8%
May 30	HC Wainwright& Co.	Maintains	Buy → Buy	—	$2.39	$2.47	+3.3%	+13.0%	+38.9%	+55.2%	+76.6%	+90.8%
May 2	HC Wainwright & Co.	Maintains	Buy → Buy	—	$2.94	$2.98	+1.4%	-1.7%	+1.4%	-1.7%	-2.4%	-2.4%
Apr 4	HC Wainwright & Co.	Maintains	Buy → Buy	—	$1.80	$1.80	+0.0%	+3.9%	+1.1%	+1.1%	+10.0%	+13.3%
Feb 13	HC Wainwright & Co.	Maintains	Buy → Buy	—	$2.15	$2.27	+5.6%	+10.2%	+16.3%	+21.9%	+18.6%	+16.7%
Feb 8	HC Wainwright & Co.	Maintains	Buy → Buy	—	$1.90	$1.86	-2.1%	+2.1%	+2.6%	+13.2%	+24.7%	+31.6%
Aug 30	HC Wainwright & Co.	Maintains	Buy → Buy	—	$1.42	$1.57	+10.6%	+12.7%	+27.5%	+31.0%	+19.0%	+13.4%
Jan 18	HC Wainwright & Co.	Maintains	Buy → Buy	—	$5.17	$4.73	-8.5%	+0.0%	+8.5%	+0.0%	-17.0%	-19.1%
Sep 7	HC Wainwright & Co.	Maintains	Buy → Buy	—	$7.04	$7.15	+1.6%	+3.1%	+0.0%	-3.1%	+1.6%	-3.1%
Feb 8	HC Wainwright & Co.	Maintains	Buy → Buy	—	$15.07	$15.84	+5.1%	+8.0%	+40.9%	+32.1%	+24.1%	+27.7%
Apr 7	HC Wainwright & Co.	Maintains	Buy → Buy	—	$22.99	$23.32	+1.4%	-3.8%	+1.4%	+6.7%	+17.2%	+20.1%
Nov 12	Piper Jaffray	Maintains	Overweight → Overweight	—	$21.01	$21.34	+1.6%	+2.6%	+5.2%	+9.9%	+9.4%	+7.3%
Jun 25	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$32.56	$33.44	+2.7%	+4.7%	+1.0%	+1.4%	+1.7%	+1.0%
Jun 24	Piper Jaffray	Maintains	Overweight → Overweight	—	$32.89	$34.10	+3.7%	-1.0%	+3.7%	+0.0%	+0.3%	+0.7%
Oct 19	IFS Securities	Downgrade	Strong Buy → Outperform	—	$47.19	$46.64	-1.2%	-1.2%	+0.2%	+0.9%	-3.5%	+0.5%
Aug 14	IFS Securities	Downgrade	Strong Buy → Buy	—	$68.64	$69.96	+1.9%	+5.0%	+2.7%	+3.0%	-0.6%	+0.8%
Nov 8	Bank of America	Downgrade	Neutral → Underperform	—	$62.26	$44.00	-29.3%	-20.3%	-13.3%	-9.7%	-3.4%	+0.7%
Aug 19	BTIG Research	Maintains	Buy → Buy	—	$81.07	$82.17	+1.4%	-2.0%	-2.0%	-1.6%	-2.8%	-5.3%
Mar 1	Craig-Hallum	Downgrade	Buy → Hold	—	$105.60	$67.10	-36.5%	-34.3%	-35.1%	-36.5%	-35.5%	-32.4%
Mar 1	Stifel Nicolaus	Downgrade	Buy → Hold	—	$105.60	$67.10	-36.5%	-34.3%	-35.1%	-36.5%	-35.5%	-32.4%
Aug 13	Morgan Stanley	Maintains	Underweight → Underweight	—	$151.14	$134.53	-11.0%	-16.0%	-7.9%	-8.0%	-11.8%	-14.9%
Jan 7	Oppenheimer	Maintains	Outperform → Outperform	—	$104.61	$111.65	+6.7%	+8.7%	+14.2%	+14.3%	+24.2%	+24.1%
Nov 7	Chardan Capital	Maintains	Buy → Buy	—	$102.63	$127.82	+24.5%	+13.1%	+16.8%	+19.5%	+20.5%	+18.0%
Aug 14	FBR Capital	Maintains	Underperform → Underperform	—	$122.65	$115.39	-5.9%	-7.9%	-8.2%	-6.8%	-7.5%	-9.4%
Dec 19	Chardan Capital	Maintains	Buy → Buy	—	$115.72	$120.01	+3.7%	+6.0%	+8.7%	+6.5%	+5.7%	+6.4%
Dec 17	Brean Capital	Maintains	Sell → Sell	—	$148.17	$127.27	-14.1%	-19.8%	-21.9%	-17.2%	-15.1%	-16.9%
Sep 13	Craig-Hallum	Maintains	Buy → Buy	—	$90.53	$98.01	+8.3%	+22.8%	+21.5%	+18.7%	+18.5%	+14.1%
May 9	Stifel Nicolaus	Maintains	Buy → Buy	—	$43.56	$45.65	+4.8%	-4.8%	-1.5%	-5.6%	-9.3%	-15.4%
Nov 27	Dawson James	Maintains	Market Outperform → Outperform	—	$79.75	$79.86	+0.1%	-1.8%	-2.3%	-1.4%	+0.4%	+0.4%
Nov 9	Stifel Nicolaus	Maintains	Buy → Buy	—	$73.04	$72.05	-1.4%	-3.8%	-5.3%	-3.8%	-9.5%	-15.8%
Apr 11	Summer Street	Maintains	Buy → Buy	—	$97.35	$99.11	+1.8%	+7.9%	+5.5%	+3.2%	+4.3%	+5.9%
Mar 12	Stifel Nicolaus	Maintains	Buy → Buy	—	$98.67	$103.07	+4.5%	+8.6%	+9.5%	+2.6%	+8.7%	+5.6%

Recent Filings

8-K

Unknown — 8-K Filing

RMTI experienced a material triggering event requiring immediate disclosure, making this 8-K critical for understanding recent developments that could significantly impact the stock's valuation and investor decision-making.

Mar 26

8-K

Unknown — 8-K Filing

Rimini Street (RMTI) achieved sustained profitability with $69.3M revenue in 2025, demonstrating business model viability and potentially supporting stock valuation multiples expansion if growth accelerates.

Mar 26

Data updated apr 26, 2026 11:11pm · Source: massive.com